LIFETECH SCI (01302) released its interim results, reporting a loss attributable to shareholders of 34.348 million yuan.
Xianjian Technology (01302) released its mid-term results for 2026, with revenue of 600.8 million yuan, a year-on-year decrease of 11.2%. The loss attributable to the companys owners amounted to 34.348 million yuan, compared to a profit of 55.074 million yuan in the same period last year. The basic loss per share is 0.08 yuan.
LIFETECH SCI (01302) announced its interim results for 2026, reporting a revenue of 600.8 million yuan, a year-on-year decrease of 11.2%; the loss attributable to equity holders of the company was 34.348 million yuan, compared to a profit of 55.074 million yuan in the same period last year; basic loss per share was 0.08 yuan.
The year-on-year decrease in revenue during the period was mainly due to reduced sales revenue from structural heart disease occluders and cardiac pacemakers.
Related Articles
IDREAMSKY (01119) Mid-year performance in 2026: Dual-driven continuous deepening, self-developed IP and AI agents collaborate to accelerate.
Longfor (00960) has reduced its debt by 5.7 billion in the first half of the year, fully repaying all credit bonds maturing within the year.
2026 Semi-Annual Report: COSMO LADY (02298) Profit Increased by 5.9%, E-commerce GMV Grew by 69.6% Year-on-Year to 2.73 Billion.
IDREAMSKY (01119) Mid-year performance in 2026: Dual-driven continuous deepening, self-developed IP and AI agents collaborate to accelerate.
Longfor (00960) has reduced its debt by 5.7 billion in the first half of the year, fully repaying all credit bonds maturing within the year.
2026 Semi-Annual Report: COSMO LADY (02298) Profit Increased by 5.9%, E-commerce GMV Grew by 69.6% Year-on-Year to 2.73 Billion.
RECOMMEND
